Lataa...
Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice
OBJECTIVE(S): Breast cancer is one of the most common cancers in the world and is on the increase. MUC1 and HER2 as tumor-associated antigens (TAAs) are abnormally expressed to some extent in 75–80% of breast cancers. In our present research, a novel chimeric MUC1-HER2 (HM) protein was designed and...
Tallennettuna:
| Julkaisussa: | Iran J Basic Med Sci |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Mashhad University of Medical Sciences
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5776432/ https://ncbi.nlm.nih.gov/pubmed/29372033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/IJBMS.2017.25686.6335 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|